Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2025-12-28 @ 3:58 PM
Study NCT ID:
NCT05049850
Status:
TERMINATED
Last Update Posted:
2025-10-21
First Post:
2021-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
Sponsor:
Hansa Biopharma AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-09
First Submit QC Date:
None
Study First Post Date:
2021-09-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-04
Results First Submit QC Date:
None
Results First Post Date:
2025-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-03
Last Update Post Date:
2025-10-21
Last Update Post Date Type:
ESTIMATED